Lepage, Margot
Gossez, Morgane
Lukaszewicz, Anne-Claire
Monneret, Guillaume
Venet, Fabienne http://orcid.org/0000-0003-0462-4235
Funding for this research was provided by:
Hospices Civils de Lyon
Article History
Received: 20 May 2022
Accepted: 17 October 2022
First Online: 31 October 2022
Declarations
:
: Septic shock patients: this study was conducted in the intensive care units (ICU) of Hospital Edouard Herriot (Lyon, France), as a part of a global study in sepsis induced immune dysfunctions (IMMUNOSEPSIS cohort). This project was approved by the Institutional Review Board for ethics (Comité de Protection des Personnes Sud-Est II, #IRB11236). This study is registered with the French Ministry of Research and Teaching (#DC-2008-509) and with the Commission Nationale de l’Informatique et des Libertés (CNIL). This study was registered at clinicaltrials.gov (NCT02803346). Non-opposition to inclusion in the study was recorded from each patient or next of kin. Healthy volunteers: peripheral blood from healthy volunteers was provided by the “Etablissement Français du Sang” from Lyon. According to EFS standardized procedures for blood donation and to provisions of the articles R.1243–49 and following ones of the French public health code, a written non-opposition to the use of donated blood for research purposes was obtained. The blood donors’ personal data were anonymized before transfer to our research laboratory.
: Not applicable.
: Metafora provided reagents in collaboration with bioMérieux. These private companies had no role in the study design, result analysis and decision to publish this study. All other authors have declared no conflicts of interest.